• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

退伍军人事务部丙型肝炎人群管理仪表板的用户体验。

User experience of a hepatitis c population management dashboard in the Department of Veterans Affairs.

机构信息

Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford, MA, United States of America.

Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, United States of America.

出版信息

PLoS One. 2023 May 2;18(5):e0285044. doi: 10.1371/journal.pone.0285044. eCollection 2023.

DOI:10.1371/journal.pone.0285044
PMID:37130107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10153746/
Abstract

BACKGROUND

The Veterans Health Administration (VA) is the largest integrated healthcare organization in the US and cares for the largest cohort of individuals with hepatitis C (HCV). A national HCV population management dashboard enabled rapid identification and treatment uptake with direct acting antiviral agents across VA hospitals. We describe the HCV dashboard (HCVDB) and evaluate its use and user experience.

METHODS

A user-centered design approach created the HCVDB to include reports based on the HCV care continuum: 1) 1945-1965 birth cohort high-risk screening, 2) linkage to care and treatment of chronic HCV, 3) treatment monitoring, 4) post-treatment to confirm cure (i.e., sustained virologic response), and 5) special populations of unstably housed Veterans. We evaluated frequency of usage and user experience with the System Usability Score (SUS) and Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) instruments.

RESULTS

Between November 2016 and July 2021, 1302 unique users accessed the HCVDB a total of 163,836 times. The linkage report was used most frequently (71%), followed by screening (13%), sustained virologic response (11%), on-treatment (4%), and special populations (<1%). Based on user feedback (n = 105), the mean SUS score was 73±16, indicating a good user experience. Overall acceptability was high with the following UTAUT2 rated from highest to least: Price Value, Performance Expectancy, Social Influence, and Facilitating Conditions.

CONCLUSIONS

The HCVDB had rapid and widespread uptake, met provider needs, and scored highly on user experience measures. Collaboration between clinicians, clinical informatics, and population health experts was essential for dashboard design and sustained use. Population health management tools have the potential for large-scale impacts on care timeliness and efficiency.

摘要

背景

退伍军人健康管理局(VA)是美国最大的综合性医疗机构,负责照顾最大的丙型肝炎(HCV)患者群体。一个全国性的 HCV 人群管理仪表板使 VA 医院能够通过直接作用抗病毒药物快速识别和接受治疗。我们描述了 HCV 仪表板(HCVDB),并评估了其使用情况和用户体验。

方法

采用以用户为中心的设计方法创建了 HCVDB,其中包括基于 HCV 护理连续体的报告:1)1945-1965 年出生队列的高危筛查,2)与护理和慢性 HCV 治疗的联系,3)治疗监测,4)治疗后的确认治愈(即持续病毒学应答),以及 5)居住不稳定的退伍军人的特殊人群。我们使用系统可用性得分(SUS)和统一接受和使用技术理论 2(UTAUT2)工具评估了使用频率和用户体验。

结果

在 2016 年 11 月至 2021 年 7 月期间,共有 1302 位用户总共访问了 HCVDB 163836 次。链接报告的使用频率最高(71%),其次是筛查(13%)、持续病毒学应答(11%)、治疗中(4%)和特殊人群(<1%)。根据用户反馈(n=105),平均 SUS 得分为 73±16,表明用户体验良好。总体接受度较高,以下 UTAUT2 评分从高到低分别为:价格价值、绩效预期、社会影响和便利条件。

结论

HCVDB 得到了快速广泛的采用,满足了提供者的需求,在用户体验方面得分很高。临床医生、临床信息学和人群健康专家之间的合作对于仪表板设计和持续使用至关重要。人群健康管理工具有可能对护理及时性和效率产生重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc98/10153746/4c0b75e285cd/pone.0285044.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc98/10153746/1bba22dcfd86/pone.0285044.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc98/10153746/f07bdeb54eb2/pone.0285044.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc98/10153746/4c0b75e285cd/pone.0285044.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc98/10153746/1bba22dcfd86/pone.0285044.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc98/10153746/f07bdeb54eb2/pone.0285044.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc98/10153746/4c0b75e285cd/pone.0285044.g003.jpg

相似文献

1
User experience of a hepatitis c population management dashboard in the Department of Veterans Affairs.退伍军人事务部丙型肝炎人群管理仪表板的用户体验。
PLoS One. 2023 May 2;18(5):e0285044. doi: 10.1371/journal.pone.0285044. eCollection 2023.
2
Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.美国退伍军人事务部丙型肝炎病毒治疗连续护理在直接作用抗病毒药物时代的成功。
Clin Infect Dis. 2024 Jun 14;78(6):1571-1579. doi: 10.1093/cid/ciae025.
3
Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.丙型肝炎治愈与退伍军人事务回顾性队列中肝硬化患者的医疗保健费用降低有关。
Dig Dis Sci. 2018 Jun;63(6):1454-1462. doi: 10.1007/s10620-018-4956-0. Epub 2018 Feb 16.
4
Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.治愈丙型肝炎病毒感染:美国退伍军人事务部的最佳实践。
Ann Intern Med. 2017 Oct 3;167(7):499-504. doi: 10.7326/M17-1073. Epub 2017 Sep 26.
5
Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists.通过加强临床药学专家的使用,增加丙型肝炎退伍军人的获得途径。
J Am Pharm Assoc (2003). 2019 May-Jun;59(3):398-402. doi: 10.1016/j.japh.2019.01.018. Epub 2019 Mar 8.
6
Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES).退伍军人事务部医疗保健系统中丙型肝炎病毒 (HCV) 感染治疗接受和提供者专业的趋势:电子检索 HCV 感染退伍军人队列的结果(ERCHIVES)。
Clin Infect Dis. 2019 Feb 15;68(5):857-859. doi: 10.1093/cid/ciy697.
7
Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs.美国退伍军人事务部慢性丙型肝炎病毒感染的患病率及治疗情况
Epidemiol Rev. 2015;37:131-43. doi: 10.1093/epirev/mxu002. Epub 2015 Jan 19.
8
Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.直接作用抗病毒治疗在退伍军人管理局治疗初治慢性 HCV 基因型 1 感染患者中的成本效益。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1503-10. doi: 10.1016/j.cgh.2013.05.014. Epub 2013 May 22.
9
Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.退伍军人事务部的丙型肝炎护理:为成功奠定基础。
Infect Dis Clin North Am. 2018 Jun;32(2):281-292. doi: 10.1016/j.idc.2018.02.011.
10
Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs.远程医疗专业支持促进退伍军人事务部初级保健提供者治疗丙型肝炎。
Am J Med. 2017 Apr;130(4):432-438.e3. doi: 10.1016/j.amjmed.2016.11.019. Epub 2016 Dec 18.

引用本文的文献

1
Identifying Influential Theories in Human-Computer Interaction Within Health Informatics: A Systematic Review.识别健康信息学中人机交互领域的有影响力的理论:一项系统综述。
Health Sci Rep. 2025 Jul 21;8(7):e71074. doi: 10.1002/hsr2.71074. eCollection 2025 Jul.

本文引用的文献

1
HCV Elimination in the US Department of Veterans Affairs.美国退伍军人事务部的丙型肝炎病毒消除工作。
Clin Liver Dis (Hoboken). 2021 Aug 18;18(1):1-6. doi: 10.1002/cld.1150. eCollection 2021 Jul.
2
The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance.肝脏创新团队协作组:一种成功的基于人群的肝细胞癌监测方法。
Cancers (Basel). 2021 May 7;13(9):2251. doi: 10.3390/cancers13092251.
3
Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019.
2017-2019 年,在芝加哥城市保障健康系统中,药剂师主导的丙型肝炎病毒治疗项目的结果。
Public Health Rep. 2022 Jul-Aug;137(4):702-710. doi: 10.1177/00333549211015664. Epub 2021 May 27.
4
Visual Analytic Tools and Techniques in Population Health and Health Services Research: Scoping Review.人群健康与卫生服务研究中的视觉分析工具与技术:范围综述
J Med Internet Res. 2020 Dec 3;22(12):e17892. doi: 10.2196/17892.
5
Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.2010-2019 年美国接受肝移植的男性和女性的肝病和肝细胞癌的病因和趋势。
PLoS One. 2020 Sep 18;15(9):e0239393. doi: 10.1371/journal.pone.0239393. eCollection 2020.
6
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.药师主导与常规提供的抗病毒治疗在接受阿片类药物替代治疗的丙型肝炎病毒患者中的临床效果:一项实用的、集群随机试验。
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):809-818. doi: 10.1016/S2468-1253(20)30120-5. Epub 2020 Jun 8.
7
CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.美国疾病预防控制中心关于 2020 年成年人丙型肝炎筛查的建议。
MMWR Recomm Rep. 2020 Apr 10;69(2):1-17. doi: 10.15585/mmwr.rr6902a1.
8
Hooray for the VHA! A Survey of Access and Barriers to Liver Care Among Veterans.退伍军人健康管理局万岁!退伍军人肝脏护理的获取与障碍调查。
Dig Dis Sci. 2019 Dec;64(12):3361-3362. doi: 10.1007/s10620-019-05874-2.
9
Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2.纵向评估实施策略使用与丙型肝炎治疗采用之间的关联:第 2 年。
Implement Sci. 2019 Apr 8;14(1):36. doi: 10.1186/s13012-019-0881-7.
10
Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.退伍军人事务部的丙型肝炎护理:为成功奠定基础。
Infect Dis Clin North Am. 2018 Jun;32(2):281-292. doi: 10.1016/j.idc.2018.02.011.